PURPOSE OF REVIEW: Pediatric brain tumors differ from those arising in adulthood. This article discusses the presentation, location, histology, new molecular understanding, therapy, and outcome of brain tumors in children. RECENT FINDINGS: Improved biological understanding of pediatric brain tumors is resulting in new molecular-based classification and the development of rationally designed therapeutics. SUMMARY: The presentation of a pediatric brain tumor is dependent on the type of tumor, its location in the nervous system, and the age of the child. Diagnostic workup varies depending on the location of the tumor and the tumor's propensity to disseminate in the nervous system. Survival has improved for pediatric brain tumors, particularly medulloblastoma, as a result of improved surgical techniques and rational use of postoperative radiation and chemotherapy. For medulloblastoma, recent studies have sought to maintain or improve survival while decreasing neurologic sequelae, particularly from radiation in young children. For other childhood brain tumor types, improvements in outcome are not as clear-cut. New molecular insights will likely alter classification, risk stratification, and therapy in the near future.
PURPOSE OF REVIEW: Pediatric brain tumors differ from those arising in adulthood. This article discusses the presentation, location, histology, new molecular understanding, therapy, and outcome of brain tumors in children. RECENT FINDINGS: Improved biological understanding of pediatric brain tumors is resulting in new molecular-based classification and the development of rationally designed therapeutics. SUMMARY: The presentation of a pediatric brain tumor is dependent on the type of tumor, its location in the nervous system, and the age of the child. Diagnostic workup varies depending on the location of the tumor and the tumor's propensity to disseminate in the nervous system. Survival has improved for pediatric brain tumors, particularly medulloblastoma, as a result of improved surgical techniques and rational use of postoperative radiation and chemotherapy. For medulloblastoma, recent studies have sought to maintain or improve survival while decreasing neurologic sequelae, particularly from radiation in young children. For other childhood brain tumor types, improvements in outcome are not as clear-cut. New molecular insights will likely alter classification, risk stratification, and therapy in the near future.
Authors: Alexia Klonou; Danai Spiliotakopoulou; Marios S Themistocleous; Christina Piperi; Athanasios G Papavassiliou Journal: Ann Transl Med Date: 2018-06
Authors: Alexia Klonou; Christina Piperi; Antonios N Gargalionis; Athanasios G Papavassiliou Journal: Neuromolecular Med Date: 2017-07-26 Impact factor: 3.843
Authors: Eduardo Javier Barragán-Pérez; Carlos Enrique Altamirano-Vergara; Daniel Eduardo Alvarez-Amado; Juan Carlos García-Beristain; Fernando Chico-Ponce-de-León; Vicente González-Carranza; Luis Juárez-Villegas; Chiharu Murata Journal: Pathol Oncol Res Date: 2020-07-13 Impact factor: 2.874
Authors: Maurizio Bruschi; Andrea Petretto; Armando Cama; Marco Pavanello; Martina Bartolucci; Giovanni Morana; Luca Antonio Ramenghi; Maria Luisa Garré; Gian Marco Ghiggeri; Isabella Panfoli; Giovanni Candiano Journal: Sci Rep Date: 2021-01-19 Impact factor: 4.379
Authors: Antonio Ruggiero; Anna Ariano; Silvia Triarico; Michele Antonio Capozza; Alberto Romano; Palma Maurizi; Stefano Mastrangelo; Giorgio Attinà Journal: Drugs Context Date: 2020-06-02
Authors: Sévérine de Bruijn; Sébastien Anguille; Joris Verlooy; Evelien L Smits; Viggo F van Tendeloo; Maxime de Laere; Koenraad Norga; Zwi N Berneman; Eva Lion Journal: Cancers (Basel) Date: 2019-09-19 Impact factor: 6.639